Dec3

Stories to Tell: Facebook for Health Care Brands

Stories to Tell Facebook for Health Care Brands BLOG Image2We all know Facebook is a powerful storytelling platform for brands. But in health care, FDA regulation and privacy rules often leave us watching our counterparts in consumer marketing with jealousy. A recent example of our work with Hackensack University Medical Center demonstrates not only that health care brands can carry out effective content strategies on social media platforms, it can even be simple to accomplish.

HackensackUMC is consistently rated as the top hospital in New Jersey by US News & World Reports. One particular area of excellence is its nursing program. The hospital is one of just two in the nation to earn the prestigious Magnet nursing designation five consecutive times, representing 20 years of distinction.

Last May, during National Nurses Week, we proposed creating a series of Facebook posts where each day would feature a short story and photo of a HackensackUMC nurse.

The work was minimal: we conducted a 20 minute phone interview with each nurse and asked him or her to provide us with a photo. The response was tremendous: The stories we posted about each nurse quickly became the most engaging content the hospital has ever posted on its Facebook page.

Of particular note, on Wednesday of National Nurses Week, the story of about Dennis Leenig Jr., a pediatric oncology nurse, received over 450 likes, 50 comments and 25 shares. Here’s the post:

It’s not unusual to find Dennis Leenig, Jr. sitting and talking with a patient a half hour after his shift has finished for the day. “Working with leukemia patients, I like that I get to see people through all stages of their care. You get to establish a rapport,” he says. It’s a relationship that continues even after a patient has gone home. Dennis always conducts follow up calls to patients after they’re discharged to see how they’re feeling and to make sure they’re not having trouble getting any medications. “Patients have told me I’m like a son to them and that means the world to me.” Dennis remembers when his own father was a cancer patient at HackensackUMC. A nursing student at the time, it was while visiting his father that he realized his calling was in oncology.

Even more powerful than what we wrote about Dennis, were the testimonials that former patients posted in the comments section. Some excerpts:

Hey Dennis, I remember you well. I felt like I was in expert hands and it was clear to me that your concern for my wellbeing was sincere and genuine. Thank you for making a stressful event a little less so.

We love Dennis and know him well after having many visits to 8PW over the past 4 years with our son. His love and dedication to all patients goes above and beyond. Thank you, Dennis, for all that you do. You have become like family to us.

Dennis, when my uncle was in your care I felt reassured knowing that he had an all-around great guy to help him. He really liked you and spoke highly of you. He fought a good fight but the cancer was too aggressive. I have the utmost respect for what you do on a daily basis and I wanted to thank you again (and the rest of the doctors, nurses, and staff) for everything you did to make his life more comfortable when he was in your care.

The marketing and PR value of these posts is obvious. Who wouldn’t want to go to a place with such compassionate, attentive care? And Dennis was just one of seven nurses we featured that week.

But another benefit of sharing these stories on Facebook is easy to overlook: Facebook as an internal communications tool. The nurses were honored that we thought to interview them for the Facebook page and proud to receive public recognition for their work. And their colleagues enjoyed reading the stories and having a public place to record their praise. It was a morale boost all around.

We are constantly uncovering great stories like Dennis’s. But in this regard, HackensackUMC is not unique. All of our clients’ organizations are brimming with stories.

Maybe it’s easier to find them in a hospital, where nurses are touching lives every hour of every day. But great stories are everywhere–even in corporate settings. What motivated a pharmaceutical company executive to enter the health care industry? Why did a research scientist decide to focus on this particular disease state?

The answers to these questions are personal stories. Telling them brings out the human side of a corporation and pulls employees closer together. New media tools like Facebook make it easy to bring them to the public. And the public is hungry hear these stories from your brand. Especially in health care.

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at blog@ochww.com.
Please allow 24 hours for response.

Also posted in Apps, Brand Awareness, Branding, Culture, Digital, Healthcare Communications, Strategy | Tagged | Leave a comment
Nov12

Ebola Goes Viral

Ebola Blog Image2“It’s like the film with Dustin Hoffman and the monkeys,” said the woman next to me on the tube the other day. “No, it’s more like that other film with the monkeys,” said her companion. “The one where animal rights protestors release them and unleash a zombie virus on the UK.”

The truth, thankfully, is that the most recent Ebola outbreak is nothing like either of these movies. The Ebola virus has yet to mutate into a new strain that spreads like flu as it does so rapidly in Outbreak, and it seems somewhat unlikely that it is going to turn us all into flesh-eating un-dead as happens in 28 Days Later. But what exactly is it like, how much of a threat does it pose, and how are we supposed to communicate the bare facts of virus and disease in an atmosphere of panic and misinformation?

The other day, news outlets were tracing the steps of one of Ebola’s recent victims. New Yorker Dr. Craig Spencer had been all around town since returning from aid work in Guinea. He had taken the subway, visited a meatball stand and hung out at a bowling alley in Brooklyn. Normal things that a person might like to do after returning to their hometown after an intense trip abroad. But Dr. Spencer started running a high fever and was soon diagnosed with an Ebola virus infection.

Despite most reports suggesting that he had interacted with only a handful of people since becoming symptomatic, The Gutter, the bowling alley visited by Dr. Spencer, was forced to close down for two days and underwent a mass disinfection. The Meatball Shop remained open but was host to a PR stunt in which the city’s mayor visited for a meal in front of a host of cameras to prove to the general public it was safe. Which of course both of these places should be. There is nothing about the pathogenesis of Ebola that suggests we can catch it from a bowling ball or a restaurant table. Indeed the virus can barely survive for long outside the body, especially on hard, dry surfaces.

Hysterical news reporting of disease is nothing new. This time, like many other times before, it has been served up with a dollop of xenophobia. The problem, almost ignored when it is abroad and confined to countries that barely register on the Western consciousness, is treated like an unmitigated disaster when it hits home shores. Like the wave of homophobia that emerged in the wake of the HIV/AIDS crisis of the early ’80s, the tabloid media emphasis is on minimizing personal risk rather than pressuring organizations such as the UN and the WHO to act on the virus itself. We are encouraged to shut our borders, be suspicious, be vigilant, and most importantly, be afraid.

If there is something that feels different this time around, it’s the social media factor. In 2009 when swine flu panic was at its peak, we were all on Facebook, but fewer of us were active on Twitter. The surges of popularity in micro-media over the past few years have completely changed the way we consume and digest news, but also the speed at which stories spread.

Take the case of this video, which was recorded in a Chilean hospital a few weeks ago. The announcement you hear roughly translates as: “Can I have your attention, please. We have a patient who is suspected to have Ebola. Please leave the room and go to another hospital.” After the patient who took this video posted it on YouTube, it received almost 140,000 views. Soon the story migrated to Twitter, where the hashtag #EbolaChile was used over 200,000 times. All this happened incredibly fast and internationally, even though it was later revealed that the suspected Ebola was actually a case of malaria. Indeed, it has not gone unnoticed that the Ebola news is spreading faster than the virus itself.

But when things are over-egged on Twitter it only ever results in topic fatigue and silliness. Recently, actress Anne Hathaway was accused of refusing to shake an Argentinian journalist’s hand due to fear of contracting the virus. Others are making mockery of the intense US media coverage, with some users suggesting that “EBoLa could be the name of an obnoxious Manhattan neighborhood” or that “the only part of the Ebola guy that upsets me is how rich his social life seems in comparison.”

With the fast pace of social media reporting, topics that have had everyone enraged on one day can be forgotten the next. But whilst it’s easy to laugh at the jokes made at the expense of the media hysteria in the US, for the people of the West African countries most affected it is a genuine threat, and it’s not going away.

Organizations like the CDC are doing a good job of keeping up sensible dialogue about Ebola by producing factsheets on the disease and its transmission. These are clearly designed to alleviate fears about how the virus has been spread without shying away from the facts of how it is affecting the West African countries hit by the epidemic. The UN has been providing updates on the current situation, and what they are doing to combat the spread of the disease whilst the WHO have tweeted audio files from their recent press conference. The challenge for these organizations is that there is a lot of repetition in the messages that they have to send out. The advice about the virus is quite basic and in order for them to communicate this effectively they have to find new and interesting ways to dress up the facts, so as not to appear repetitive.

When developing our own disease awareness initiatives we can learn from the social media reaction to Ebola. Twitter can be a maelstrom of misinformation and flippancy, and it is important to provide clear, concise and meaningful content such as infographics and video. Although rather than share PDFs, like the organizations mentioned above, we should think about content that is easily viewable and sharable within a Twitter client. Most importantly we should remember that it’s easy for a story to get lost in a medium that moves as fast as social. Bitesize content should be deployed regularly to keep up the momentum, and we need to find creative ways of saying the same messages in different ways so we make our point without switching off our audience.

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at blog@ochww.com.
Please allow 24 hours for response.

Also posted in Creativity, Culture, Design, Digital, Health & Wellness, Healthcare Communications, Media, Strategy | Tagged | Leave a comment
Nov6

Are You Listening?

8370148From predictive sentiment analysis and word association to audience profiling and message personalization, social listening techniques are helping healthcare marketers translate everyday conversations into brand positioning strategies, outreach programs, and relevant online content.

With the exponential growth in social sharing and social media, we posed the question, “Are You Listening” to the healthcare industry during a recent panel discussion on social listening at Ogilvy CommonHealth Worldwide’s 3rd Annual Marketing Analytics & Consulting Summit. The reaction to the discussion during the summit was incredible, as attendees bombarded our panelists with questions, which made for a lively discussion.

Joining our expert panel discussion were several contributors: Ryan Alovis, InTouchMD, Karen Auteri, IMS Health, Michele Baer, Feinstein Kean Healthcare, Kim-Fredrick Schneider, Sermo, and our very own Angelo Campano, Ogilvy Healthworld.

Untitled

Attendees learned multiple perspectives from our expert panelists. First, social listening provides marketers with a reality check for what patients and physicians are discussing in terms of disease states, available drugs, and lifestyle considerations. Second, attendees learned that many of the techniques employed have been shown to help marketers manage and respond to adverse events and reposition web content to deliver more meaningful messages to audiences they are trying to reach and educate.

Our Approach

Making sense of social conversations as related to branded and unbranded messages, and disease states, is central to capturing emerging patient and physician trends around sentiment, preference, and message personalization. In the Analytics department at Ogilvy CommonHealth Worldwide, we believe social listening needs to be a dynamic discipline that is “always on” and can be configured to leverage our sophisticated network of algorithms to aggregate unstructured conversations, and glean meaningful insights related to the way patients and physicians are talking about our clients’ products.

Natural Language Processing (NPL) and text mining machine learning algorithms are used to extract dominant concepts across posts, tweets, text messages, and call center conversations. We create a dictionary of terms with the highest frequency across messages, which is also known as a term document matrix. Correlation analyses are run across the document matrix to isolate the top 100 concepts and messages. This concept investigation is done through splitting the data into a training dataset and a test dataset (usually a 70/30 split, respectively). We then apply decision trees and neural networks to learn from our sample training data on how the text in each comment is configured to help derive classification rules on sentiment (positive or negative). Once classification rules are set, our rules are then deployed for overall monthly scoring of brand sentiment.

Untitled2

We can help our clients understand questions such as:

  • What are HCP and patient sentiments about the brand?
  • What are the terms and attributes HCPs and patients are using to refer to our ailment state or specific brand?
  • What are HCPs and patients saying about competitor brands?
  • How can we proactively manage adverse events reporting?

Notable Applications

With limited social buzz, a cancer drug maker found that their brand’s category was mostly associated with terms like LDK-378, crizotinib and maintenance terms. The brand itself was strongly associated with terms like Tarceva and ALK, but social listening allowed the brand to identify opportunities within the category to purchase tertiary or long-tail terms to optimize search.

In addition to finding ways to optimize search, we were able to identify three different types of back pain sufferers through social listening. From over 115,000 local EU market conversations, we were able to identify pre-concerned, seekers, and diagnosed back pain sufferers. This learning enabled our marketing plan to amplify key brand messages at the right moment, in the right space, and at the right time that was most relevant to when each audience was most likely to respond.

Offering Many Benefits

Through understanding and evaluating the reality of how patients and physicians are talking about disease states, branded or unbranded products, we’ve reshaped website content, fine-tuned campaign messages, optimized SEO, and considered new targeting pathways. Our processes will continue to evolve to help drug manufacturers become more relevant in meeting physician information and patient care needs.

If you’re not listening, our Analytics group at Ogilvy CommonHealth Worldwide can help get you started.

 

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at blog@ochww.com.
Please allow 24 hours for response.

Also posted in Analytics, Branding, Data, Digital, Statistics, Technology | Leave a comment
Jul9

Is Print Dead?

4144823A lot has changed in print production since I entered advertising in 1987. Back in the day, printing was a form of art. A good printer was worth his or her weight in gold.

But how times have changed! Especially within the last four to five years. Art has taken a back seat, and it is down to price and speed. So what is a print buyer to do in this day and age? Is print going the way of the dinosaurs?

As I think about it, reviewing the latest research and trend reports, I have mixed feelings. I am a print person, I need it in my hand, but that doesn’t stop me from appreciating the digital world. It simply amazes me how far we have come since I started in this business. Google, YouTube, Pinterest, etc. You can find anything you need within seconds. How cool is that?

But hear this! Print is not dead and still has an important place. Just as radio did not bring the death of newspaper, and television did not bring the death of radio, online media will not kill off print media. A wise marketing plan must include a combination of both digital and print. Target your audience, apply segmentation, and adapt the resource allocation based on how your stakeholders prefer to receive their information. And of course, overlayed with analytics!

Print continues to have undeniable advantages over online advertising. It is narrowly targetable, highly personal, and credible to consumers. People trust the printed page. Audience specificity is guaranteed when trying to reach your customers.

In addition, print is tactile, a comfort food for the brain. Consumers are more engaged reading print, unlike websites, which are often skimmed in as little as 15 seconds. Studies have shown that people read digital screen text slower than printed paper and read less of it.

Technology is playing a vital role as well in print. Through the Ogilvy Innovation Lab and emerging technology, unique advances in printing—such as embedding video, QR codes and even adding smell into print—have not only made this channel more interactive, but more engaging as well.

Print is also relatively long-lived while being a solid vehicle for establishing brand identity. Print advertising will continue to be a viable component for an effective multichannel campaign. Understand your customers and how they want to receive information on your product by using the right vehicles:  real-time analytics will help inform your mix of online, print, collateral and event marketing to ensure your campaign is a winner.

So don’t ignore print. It still plays an important role in your brand’s promotional campaign. I just can’t help wondering how the next decade will affect the advertising world….

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at
blog@ochww.com.
Please allow 24 hours for response.

Also posted in advertising, content marketing, Customer Relationship Marketing, Digital, Digital Advertising, Direct-to-Consumer, Media, Personal Reflections, Technology | Tagged , , , , , , , | Leave a comment
Jul2

FDA Social Media Draft Guidance Released June 2014

fdaLeading up to its final guidance to be released in July 2014, the FDA has released draft guidance on how pharmaceutical companies and medical device manufacturers should interact with social media platforms with regard to fair balance and brand messaging. The first part of the recently released recommendations is focused on how companies post advertising and promotional messages to Internet and social media platforms with character space  limitations, such as Twitter and Google Sitelinks. The second part of the recommendations addresses how pharmaceutical and medical device companies may correct independent third-party misinformation about their brands online. While this guidance is recommended and not required, it will be beneficial for pharmaceutical companies to adopt the FDA recommendations going forward.

A brief review of the FDA recommendations is listed below, along with suggestions for practical implementation.

Internet and social media platforms with character space limitations

In its draft guidance Internet/Social Media Platforms with Character Space Limitations—Presenting Risk and Benefit Information for Prescription Drugs and Medical Devices, the FDA outlines its recommendations for promotion of brand and product information using Twitter and other character-space-limited communications, such as Google Sitelinks. The recommendations are direct and seek to include fair balance in each individual communication.

The most salient points are as follows:

  • Reminder communications, which call attention to the name of a product but do not make claims, are exempt from this guidance
  • The full indication must be used when making claims in a communication
  • Benefit information should be accompanied by risk information within each individual communication
  • The content of risk information presented should, at a minimum, include the most serious risks associated with the product
  • A direct link to a more complete discussion of risk information about the product must be included in the communication

While a link to the ISI is adequate in such communications, the FDA further recommends that companies develop landing pages devoted exclusively to the communication of risk information about their products (e.g., www.product.com/risk). The format for the URL and landing page should clearly communicate that the destination will explain the risks associated with the product.

Many social media tools automatically use link shorteners to keep within the character space limitations of the communications. While the FDA does not directly oppose the use of shorteners, it recommends that the resulting URL denote to the user that the landing page contains risk information. (For example, prod.uct/risk clearly communicates that the destination is about risk.) Another solution to character space limitations is for the company to register shorter domain names that can then redirect to its product sites for use in social media.

One challenge that brands with black box warnings will face following this guidance, especially on Twitter, is in fully communicating risk information within a single tweet. For such brands it will be impossible to communicate all risks in the platform-restricted space; therefore, we recommend against using Twitter as a channel to communicate those products’ indications, benefits, and risks.

The FDA guidance also extends to paid search communications, such as Google Sitelinks. The Sitelinks feature displays up to 6 additional destination URLs for users to choose from when a paid search ad is displayed. In complying with the FDA’s draft guidance, most of the additional destination URLs provided by the brand would link to risk information in an attempt at fair balance, which might portray the product as riskier than it actually is. This might deter some companies from using Sitelinks to promote their products.

Correcting third-party misinformation

The second round of draft guidance from the FDA, Internet/Social Media Platforms: Correcting Independent Third-Party Misinformation About Prescription Drugs and Medical Devices, seeks to improve the quality of public health information by allowing companies to correct third-party misinformation that they find online about their products. Again, these are recommendations; it is not required that a company respond to such misinformation, regardless of whether it appears on a company’s own forum or on an independent third-party forum or website.

The FDA defines misinformation as positive or negative representations or implications about a company’s product by an independent third party. There are two types of misinformation: a misrepresentation of the label, which a brand will typically want to correct, and an exaggeration of outcomes, which a brand may be tempted to leave uncorrected. The FDA recommends that companies respond to both types of misinformation.

If a company decides to correct misinformation on a third-party site, it should:

  • Provide corrective information and a link to corrective information
  • Post corrective information alongside the misinformation or refer to the misinformation in its response
  • Limit the scope of the corrective information to be specific to the misinformation, and keep it non-promotional
  • Correct positive misinformation as well as negative misinformation
  • Keep records of corrective interactions

The FDA clearly states that it will not hold a company accountable for an independent third party’s subsequent actions or lack thereof after corrective information has been supplied. Further, companies do not have to continue to monitor the third-party site after information has been corrected.

Going forward

While it is not feasible for a company to monitor all third-party sites for misinformation about its products, creating Google alerts (or similar) will help ensure that it is notified when user-generated content (UGC) about its products is trending. A company can then respond appropriately if they desire. However, consideration must be given to the level of time and effort that legal and regulatory teams must spend reviewing and filing the corrections versus the impact smaller third-party sites and individual bloggers can have on public health information.

Alternately, a company can and should focus its attention to more prominent third-party sites, such as WebMD, Wikipedia, and brand-specific hubs, in their quest to correct misinformation. This will maximize the intention of correcting the message while appropriately weighting the effort.

Overall, the draft guidance marks a significant milestone in the pharmaceutical industry’s ability to keep pace with other industries in the social media space where consumers are increasingly seeking out health information. This guidance has been a long time coming, and now pharmaceutical companies can jump into social media knowing they will be FDA compliant when the final guidance is released.

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at
blog@ochww.com.
Please allow 24 hours for response.

Also posted in advertising, content marketing, Digital Advertising, Health & Wellness, Healthcare Communications, Marketing, Technology | Tagged , , , , | Leave a comment
Jun4

The Future of Journalism

reporter with camWatching the BBC news the other night, my partner Ben turned to me and asked, “What’s wrong with that reporter’s eyes? It looks like he’s checking himself out in a mirror somewhere.” He was right, the reporter was checking himself out, but it wasn’t in a mirror – he was looking at himself in the viewfinder of his video camera. Much like Tom Daly in his famous ‘coming out’ video – this journalist was recording himself, making the rookie mistake of not locking eyes on the lens, but rather admiring himself.

Video journalism, where the TV news reporter has no crew and does everything themselves, is not new. In fact a decade ago, it was touted as a great way to break into the industry as a rookie reporter. Usually video journalists worked for small television stations or were covering stories in remote parts of the world – on their own. Few people wanted to do it, so video journalism was reserved for stories which didn’t warrant standard quality pictures or audio – I mean you can forgive the shaky or out of focus pictures when the story is coming from war-torn Bosnia!

In this instance, however, the story was coming from the relative safety of East London. Why then, with Broadcasting House virtually in shouting distance, is the Capital’s premier news service using video journalists? The fact is, video journalism has become mainstream and is virtually compulsory on metropolitan newscasts and 24 hour news channels. As public relations practitioners, we’re acutely aware of shrinking newsrooms and cuts to editorial staff across the news media – and healthcare media are no exception. The rise of video journalism is one way on-the-spot reporting has survived in a budget conscious media environment. In fact, some online medical media outlets have actually grown their video news in recent years.

So, in a post ‘information superhighway’ world (remember that chestnut?) where to for journalism? The truth is, news tastes are driven by the audience and as an audience, we’re increasingly less willing to wait for carefully gathered, edited and produced news.  Journalism today is a constant tug-of-war between getting it right and getting it right now – and it’s hard to foresee this trend changing.

Immediacy is increasingly trumping quality as a battle for the ever illusive scope wages on. Journalists are fighting bloggers, gossip merchants and even Joe Public to break a story. The only trouble is, professional journalists have the onus of at least trying to get the facts right.

So not only must a journalist get the story out first, she must also be seen as an authority on the matter and be the most prolific reporter. How else would she have any cred on Twitter? When success as a journalist can equally be measured in Twitter followers as the quality of their work – journalism today requires balancing one’s online clout with actually producing quality news copy. So worried is the BBC about the focus moving toward the former, it issued guidelines in 2012 warning journalists not to break a story on Twitter before informing their newsroom colleagues.

As PR’s, we’re increasingly aware of evolving our output to service the needs of the busy multi-platform journitator. After some tweetable nuggets? Every press release will contain some. Need an on-the-spot TV studio for a quick video interview? We’ve got one waiting for you. Want to write your story two weeks in advance for an autofile while you’re trekking in the Himalayas? No problem, we’ll sort you out with an embargoed brief and interview.

It’s hard to say how journalism will evolve over the next decade, but it’s clear the pressure for immediacy is about as high as it could possibly get. With this immediacy comes a power shift from the outlet to the story teller themselves. For the time being at least, this opens up a broad opportunity for PR’s to offer tailored content across multiple platforms – albeit to a shrinking number of journalists.

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at blog@ochww.com.
Please allow 24 hours for response.

Also posted in Blogging, Digital, Healthcare Communications, Media, Public Relations, Strategy, Technology, Video | Tagged , , , , , | Leave a comment
May14

Social Media for Pharma?

stethoscope social mediaHave you been looking for a way for your brand to engage in social media? Are you unsure of what the draft FDA guidance on social media means? Looking for some tips to help get you started? If so, you’re in the right place.

Social media has been an integral part of the digital marketer’s toolbox for several years. It is especially useful for driving brand awareness and generating site traffic. Unfortunately, due to the tightly regulated nature of the pharmaceutical industry, many have been reluctant to implement social media campaigns. Brand marketers have avoided them due to a lack of clear guidance from the FDA, and medical/regulatory review teams have refused to approve social campaigns due to the fear of receiving a dreaded FDA letter.

With the release of draft guidelines by the FDA in January, our industry has been provided with long-awaited parameters. Final guidelines have yet to be issued, but this is a step in the right direction. Slowly, pharmaceutical marketers are dipping their toes in the water. Here is a quick overview of the FDA’s guidance:

  • Brands are responsible for monitoring the content they publish. Content that is repurposed, posted, or used in an inappropriate way is not the responsibility of the pharmaceutical company (as long as the individual repurposing the content is not employed by the pharmaceutical company).
  • Pharmaceutical companies are not responsible for content published by associations and other partners that it provides with financial support (eg, unrestricted educational grants). Content and assets provided are the responsibility of the pharmaceutical company and must still go through typical FDA sampling.
  • Pharmaceutical companies and their representatives must clearly identify their association with brands when participating in conversations.
  • Fair balance is still in full effect. As with any other promotional medium, claims must be counterbalanced with the risks of the drug.
  • FDA submissions of interactions do not have to be submitted in real-time. Conversations that take place can be sampled after the fact to keep brands in compliance.

You can access the full document here.

Feeling more comfortable with the guidelines? Are you ready to deploy a social media campaign? Here are some tips to get you started:

  • Start with a strategy. As obvious as this seems, people are so anxious to implement a social media campaign, they dive in headfirst. Ensure you identify the goal of your campaign so you can measure the results of your efforts.
  • Engage in conversations with your audience. People use social media to connect with people, rarely with brands. Talk to them about topics that matter to them and are appropriately linked to your brand (eg, an antidepressant sponsoring a support forum providing tips to patients and caregivers on ways to remain positive and the importance of adherence).

According to a 2012 channel preferences research report published by ExactTarget, Facebook and Twitter rank at the bottom (4% and 1%, respectively) of channels participants want used for promotional messaging. This accentuates the importance of finding a healthy balance between brand promotion and human interaction. You can access the research here.

  • Messages must be relevant and fresh. They must take into account the context, location and intention of your audience. Not every opportunity that arises to share your marketing message should be taken. Selectivity is part of the secret to success.
  • Be flexible. The future is unpredictable. For brands to thrive in social media, they must be ready to act in the blink of an eye. Editorial calendars should not be set in stone.
  • Listen closely to the feedback of your audience and take action. The most insignificant of posts can take on a life of its own, leaving marketers scrambling to control the fallout.
  • Always have a social media crisis plan in place. Sitting idly by and not taking action is tantamount to brand suicide. Does anyone remember #mcdstories, #askJPM or #myNYPD? If not, hop on Twitter and search for the aforementioned hashtags. All are examples of hashtags that turned into “bashtags” and left their respective marketing agencies scratching their heads and scrambling to minimize the damage.

Although the pharmaceutical industry is heavily regulated, social media is an opportunity to connect with your audience and should not be overlooked. With the draft FDA guidelines in hand and a sound strategy, you can now connect with consumers through social media.

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at blog@ochww.com.
Please allow 24 hours for response.

Also posted in Branding, Content Strategy, Digital, Healthcare Communications, Media, Pharmaceutical, Strategy, Technology | Tagged , , , , , | Leave a comment
May6

Visual Storytelling Part II: Audience Engagement in 4 Steps [Infographic]

Visual-Storytelling-Part-2_ThumbPlease click on the thumbnail to the left to view full infographic.

 

 

 

 

Check out Visual Storytelling Part I: Plot Your Presentation [Infographic]

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at blog@ochww.com.
Please allow 24 hours for response.

Also posted in Design, Infographics, Presentations | Tagged , , , , , , | Leave a comment
Mar25

SXSW 2014: True Potential of Social Media in Healthcare Is Still Ahead of Us

sxsw logoOver a single-week period, SXSW Interactive hosts hundreds of presentations and panels. What was interesting to note this year, compared to the last few, is that a large percentage of healthcare discussions were now hosted on the stages of the two main convention centers, alongside all major celebrity keynotes.

Among many trends and ideas that were discussed, two concepts mentioned at the “What Happens When Tech and Healthcare Meet” panel were quite memorable. Although these are just mere single examples, each testified to a number of current trends in healthcare.

Concept: DermLink—a social network-based platform that allows patients to digitally share skin conditions with dermatologists and receive real-time responses.

Why this is important: This is especially relevant to those outside major metropolitan areas, where a wait to see the local dermatologist can exceed a few weeks. We’ve all heard success stories of doctors tapping into a broad pool of peers via Twitter and Facebook. But this platform is among the first controlled, social, care-specific environments that could potentially redefine the approach and expectations for doctor-patient interaction.

Bottom line: Regardless of the success of this platform, the mere fact that this platform is gaining momentum is an indicator that the true potential of social media in healthcare is still ahead of us.

Concept: Covered—a platform that helps applicants select the most appropriate health insurance by posing a series of qualifying questions in a standard, conversational language.

Why this is important: Although standard applications have been around for quite some time, we’re starting to see a shift in the way even insurance companies need to structure their communications. Over the past decade, we’ve witnessed a similar shift in practically every single aspect of marketing communication etiquette due to social media. A simple, well-timed response to a tweet can gain greater consumer loyalty than a multimillion-dollar Super Bowl ad.

Bottom line: Consumers no longer want to be talked at. They want to be spoken with. This is no longer breaking news…rather, a well-known fact. But at last it is finally beginning to change the insurance companies’ tone of interaction with potential applicants.

SXSW Series:

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at blog@ochww.com.
Please allow 24 hours for response.

Also posted in Apps, Data, Digital, Healthcare Communications, Physician Communications, SXSW, SXSW Interactive, Technology | Tagged , , , , , , , , , | Leave a comment
Feb26

Digital Trends Impacting US Healthcare – Infographic

In the past year, digital innovations have brought about new markets and channels for digital health interactions. This infographic is a visual mapping of the technologies and innovations which are already playing a key role in shaping the future of healthcare and the experiences and journeys which surround it.

Of course the ACA is affecting healthcare coverage, but it is also affecting our healthcare experiences by placing increased importance on and driving more frequent interactions with NPs, PAs, and Pharmacists. Additionally, more priority has shifted to consumers to educate themselves and take responsibility for their own health, especially when combined with our growing culture of social media and trust networks, and recent draft guidance from the FDA. Video remains hot, but the trending has shifted to the length of videos patients are consuming, increasing its relevance to pharmaceutical marketers. Mobile and tablets continue to grow rapidly, with and quantified self driving deeper engagement though apps, not just web. Last, but certainly not least, EHR is poised to enter the next phase of meaningful use, setting the stage for a platform shake-out as certification requirements evolve to provide more and deeper data sets to systems of connected health as providers continue to on-board.

Infographic of important technologies that impact digital healthcare marketing.

Infographic of important technologies that impact digital healthcare marketing.

Technology is evolving fast, and healthcare, believe it or not, is keeping pace and even leading the charge on many fronts. Spurred on by government mandates and initiatives, innovative organizations ranging from Google and Apple to Silicon Valley startups like Practice Fusion are quickly carrying the ball forward, sometimes struggling to keep pace with consumer expectations of today’s technology. It’s these digital healthcare innovations which have set the trends affecting us today, and will carry us forward to tomorrow.

CONTINUE THE CONVERSATION: Questions? Comments? You can contact the author directly at blog@ochww.com. Please allow 24 hours for response.

Also posted in adherence, advertising, Data, Digital, Digital Advertising, Healthcare Communications, Infographics, Managed Care, Marketing, Media, Medical Education, Multi Channel Marketing, Patient Communications, Physician Communications, Research, Strategy, Technology | Tagged , , | Leave a comment